Birgit Potrafki
Analyst · BNP Paribas
Thank you. First of all, a warm welcome also from me to you. Happy to have you here. Please excuse us for struggling with the technology here. It seems like we are always jumping to the end of the presentation if we do not keep a certain time frame. So let's try to deal with that challenge. I hope it keeps everybody's attention high. As Gunnar has just said, the economic environment is not yet providing meaningful support, which somehow a bottom, but not yet really meaningful support that we can see here. What is helping us, and also Gunnar has talked about this, are the EU trade defense measures, which are having or will be having a positive impact on price levels. Despite the absence of economic tailwinds, we achieved a significant year-on-year earnings improvement. And Gunnar has shown that, and I'm really happy to see that we could reach that in all segments. All teams really did a great job here, I have to say. We expect this positive trend to continue also in the second half of the year, albeit at a somewhat slower pace than what we have seen in the first half. I will also spend some words later on that because I know you may have some different expectations here. Our performance that makes me especially happy continues to deliver really, really strong results. After half of the year, we have almost reached the full year's target. As Gunnar has laid out, from July onwards, HKM will also contribute positively both to revenue and to earnings. All this, of course, before the purchase price allocation effect. We do not, and I can say this, we do not expect any significant net cash outflow from the consolidation. If we look at the first half of the year, our net financial position is exactly where it was 1 year ago. The difference is just EUR 4 million. So quite stable year-over-year. And including the HKM consolidation, our outlook for the net financial position for the total year remains broadly stable. So I can say with confidence that the business is now increasingly well positioned to benefit from any future improvement in economic conditions. So looking at the half-year's numbers, we see on the left upper side our sales revenues amounting to EUR 4.6 billion, which is 1.6% below the previous year's level and driven by trade only, we have to say. Here, we also see economy doesn't really help. And all the other segments are stable or slightly increasing; however, only negative revenues compared to the previous year in the trade business unit. The EBITDA and the EBT are significantly above the previous year in all segments. And the main contributions, of course, are coming from Aurubis, but also a very strong contribution from steel production as well. As I mentioned before, all the others are also contributing in a good way. And here, you see a little bit grayish the figures that are not the adjusted result figures. Here, you see that even the EBT, including the evaluation effect of the exchangeable bond, is also clearly positive. If you look at the right side, working capital, we see an increased working capital of EUR 2.6 billion, mainly coming from accounts receivable, and this is increased compared to 1 year before. All of this is resulting then also in our operating profit, which reaches EUR 59 million in the first 6 months. And this has an impact on our net financial position. As I mentioned before, very stable compared to 1 year before. If you look at our income statement, and Gunnar has mentioned already and I have mentioned already the P28 contributions that are, of course, spread all over most of the items in the profit and loss statement, but let me show you the structure of the profit and loss statement where we have the biggest contributions. Here, I would like to mention 2 major, how to say, categories that lead to the fact that we have reached such a good result. One is that if we look at our cost of materials, we see in the box below a significant improvement compared to the year before of EUR 122 million. To give you also a relation, this cost of materials represents 61% of our sales revenue, whilst 1 year before, we were still spending 65% of our sales revenues for cost of materials. The other nice big figure, you see more on the right side, the plus EUR 113 million, mainly driven by the nice performance of our Aurubis participation here, also having a nice major impact on our profit and loss, and all of this resulting in the EUR 258 million EBT, and including the valuation of the exchangeable bond, also positive, EUR 76 million. Then, after taxes, we come to a result all in of EUR 43 million. Looking at our balance sheet. And here, starting with the asset side. We see an increase in our assets of EUR 374 million, driven mainly by 3 impacts. First impact, if you look at the noncurrent assets, of course, here, we see the impact of the Aurubis evaluation. This is partially compensated in a negative way because the funding we received, they decreased the investments we have made, because the funding was also related to former spending. We see that cash and securities have also increased due to the inflow of funding, and the other current assets are mainly accounts receivable. If we look at the equity and liability side, here, 2 things need to be mentioned. First, our equity ratio is stable at 42%. And second, we have a switch between long-term and current liabilities, and this is due to the remaining maturity of some of the financial instruments we are using. Coming to the cash flow statement, starting with the left side of the operating cash flow. I have mentioned the EUR 59 million we have already received in the first half of the year. One year before, we could manage to receive EUR 81 million, and the difference is mainly driven by a different way of the development of the working capital, which increased whilst in the second quarter last year, we could significantly decrease. If we look at the right side of the cash flow statement, we see that we could increase our cash up to EUR 1.2 billion. What is really nice is that we see that in all categories, we have a plus, even in the cash flow from investments and also in the cash flow from financing at a smaller amount here for the cash flow statement, investments and depreciation. We have quite an overseeable number in the first half of the year, amounting to EUR 88 million when we look at our investments. Also strongly influenced, of course, by the funding we received was EUR 290 million. For the total year, we are looking at investments of EUR 650 million, and included in this is a EUR 100 million investment in HKM. And you see that the majority of the investments go into all the business that is not [indiscernible] related because the [indiscernible] portion, for the total year, will be profiting from the funds that we have received and that we still will receive in the upcoming months. Very happy to talk about the performance program P28 because, as I have mentioned before, on the right side, you see the target, EUR 122 million. Next to that, you see what we have effectively achieved after 6 months, EUR 97 million, which is already 80% of the total year's target. As you may remember, we have significantly overachieved the targets that we set for last year. So we are quite confident that we will not only reach our target for 2026, but that we will also be able to again overachieve our target. Gunnar has also mentioned the major contributor here, you see, with above EUR 50 million, is the steel production area, followed by steel processing and technology. Again, I would like to mention that restructuring effects are not represented in this program. This is why the nice restructuring effects we have seen in trade are accounted for in a different category, not indeed 28. I mean, Gunnar has shown it. We have lost quite significant sales in the trade area, and we could improve the profit. And that is also strongly influenced, of course, by the effects that we realized due to our restructuring activities. HKM of high interest, I know, results. We will see a positive contribution in the second half of 2026 when we will consolidate HKM. And of course, this is before the purchase price allocation effect. I have mentioned that already before; we will complete that by the end of this year. And of course, the results, we will see positive impact on the revenue side. If you ask how much, you can look at how much we have shifted our guidance. That's the major portion, of course, coming from HKM. And looking at the profit side, and of course, you will ask that question: how much is the profit going to be that you will have in addition? I can say as much as this is a mid-sized double-digit million value. If we look at the balance sheet effect, of course, the consolidation of HKM will prolong our balance sheet. However, it will not change the structure as it is. We will have one positive implication, though, and this is concerning the leverage because HKM is coming with almost no debt and bringing additional EBITDA to the table. Cash impact on Dalzgitter. I know that this is one of the most, how do I say, the figures of most interest to you. And a lot of questions are asked and will be asked, of course, about single views like restructuring or investment in transformation. However, I have to really stress that we have to look at HKM as a whole. So we have money that comes from operating activities of HKM. We have the contributions from the former shareholders, and we will receive funding for the transformation. And that money, of course, will be used to transform the company, to do the restructuring and also to do the investment. So what is the figure that is, for me, the most important one to look at is if we look at Salzgitter as a whole, including HKM, how much additional cash overall will be required due to the fact that we now own HKM. I can disclose the figure that is mentioned here, which is that, within the next 3 years, the net additional cash over all of these items that I have mentioned just right now, we will need EUR 100 million over the next 3 years. So I think that's quite an overseeable amount. And of course, since we talk a lot about SALCOS and since you are all very familiar with the SALCOS figures, it's just logical that we also talk about the investments for the transformation at HKM. And here, we are talking about around EUR 900 million, and we will receive EUR 200 million in funding. As I mentioned before, there is no need to be, how to say, concerned because the overall holistic view shows that in the next 3 years it is around EUR 100 million net additional cash that this will require. So that is the number I ask you to keep in mind. Bringing all of this together, looking at our guidance, of course, you have seen that our sales amounts are now up to EUR 10 billion, EBITDA between EUR 725 million and EUR 825 million, a pretax result between EUR 325 million and EUR 425 million, and the return on capital employed marginally above the previous year's figures. And I also know that you are challenging us again on whether we are being too prudent rather than being too bold, looking at where we are after the first half of the year and comparing that to our guidance. I can tell you, we feel quite confident with our guidance. I would also like to already give you some information here. Why is this the case? First of all, we will have seasonal effects, as we always do have coming from the summer period and coming from the Christmas period. We will have downtime for maintenance, of course, influencing the business. We had a one-time effect in the first half of the year, not sustainable effects with around about EUR 20 million. And taking all this into account, we think that we will still continue the nice path we have seen in the first half of the year. However, as I have mentioned in my introduction, a little bit, very slightly more moderate. With this, I think we are starting now the Q&A session and are getting ready or are ready to receive your questions.